Belle Mead, NJ, United States of America

Anila Bhan

This inventor holds 1 USPTO granted patent. Top assignee: Amersham Biosciences Corp. Active years: 2005.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anila Bhan: Innovator in Oligonucleotide Purification

Introduction

Anila Bhan is a notable inventor based in Belle Mead, NJ (US). She has made significant contributions to the field of biochemistry, particularly in the purification of oligonucleotides. Her innovative methods have the potential to enhance the efficiency of oligonucleotide production.

Latest Patents

Anila Bhan holds a patent for a method titled "Method for deprotecting oligonucleotides." This method involves purifying an oligonucleotide that is attached to a substrate and contains phosphate protecting groups. The process includes contacting the oligonucleotide with a reagent, such as an organic amine, which cleaves the phosphate protecting groups without detaching the oligonucleotide from the substrate. The oligonucleotide is then isolated from the cleaved phosphate protecting groups, allowing for higher yields of the desired full-length oligonucleotide product. This innovative approach simplifies the purification of crude oligonucleotide mixtures.

Career Highlights

Anila Bhan is currently associated with Amersham Biosciences Corporation, where she applies her expertise in biochemistry and molecular biology. Her work focuses on developing methods that improve the efficiency and yield of oligonucleotide production.

Collaborations

Anila collaborates with Lars Holmberg, contributing to advancements in their field through shared knowledge and expertise.

Conclusion

Anila Bhan's contributions to the field of oligonucleotide purification exemplify her innovative spirit and dedication to scientific advancement. Her patented method represents a significant step forward in the efficiency of oligonucleotide production.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…